These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 13463081)

  • 1. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
    SCHEINBERG IH; MORELL AG
    J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH
    Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521
    [No Abstract]   [Full Text] [Related]  

  • 3. Observations on ceruloplasmin in Wilson's disease.
    SASS-KORTSAK A; CHERNIAK M; GEIGER DW; SLATER RJ
    J Clin Invest; 1959 Oct; 38(10 Pt 1-2):1672-82. PubMed ID: 14441876
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
    Kanai M; Nomoto S; Tsukagoshi H; Shindo M
    Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tests of ceruloplasmin substitution in hepatocerebral degeneration (Wilson's disease)].
    BICKEL H; GOLLNER I; GRUTER W; SCHULTZE HE
    Klin Wochenschr; 1956 Sep; 34(35-36):961-8. PubMed ID: 13377617
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin].
    Wald I; Galewicz A; Górska D
    Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660
    [No Abstract]   [Full Text] [Related]  

  • 7. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH; GITLIN D
    Science; 1952 Oct; 116(3018):484-5. PubMed ID: 12994898
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease.
    CARTWRIGHT GE; MARKOWITZ H; SHIELDS GS; WINTROBE MM
    Am J Med; 1960 Apr; 28():555-63. PubMed ID: 13808058
    [No Abstract]   [Full Text] [Related]  

  • 9. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma and erythrocyte copper, zinc, manganese and magnesium concentrations in Wilson's disease.
    Goto I; Kawano Y; Tsuchiya T; Tamagawa Y; Kuroiwa Y
    Clin Neurol Neurosurg; 1986; 88(3):193-6. PubMed ID: 3780108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathobiochemistry of Wilson's disease].
    Biesold D; Lössner J; Bachmann H; Zotter J
    Z Med Lab Diagn; 1982 Oct; 23(5):278-84. PubMed ID: 7180077
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and purification of ceruloplasmin in oculocutaneous albinism, Menkes' disease, Wilson's disease and pregnant women.
    Mallet B; Aquaron R
    Clin Chim Acta; 1983 Aug; 132(3):245-56. PubMed ID: 6616879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [COPPER METABOLISM AND WILSON'S DISEASE].
    LANGE J
    Verh Dtsch Ges Inn Med; 1964; 70():330-7. PubMed ID: 14294237
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum copper, ceruloplasmin and 24-h urine copper evaluations in celiac patients.
    Ince AT; Kayadibi H; Soylu A; Ovunç O; Gültepe M; Toros AB; Yaşar B; Kendir T; Abut E
    Dig Dis Sci; 2008 Jun; 53(6):1564-72. PubMed ID: 17934856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caeruloplasmin in Wilson's disease.
    ROSENOER VM; FRANGLEN G
    Lancet; 1959 Dec; 2(7113):1163-4. PubMed ID: 14439030
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hepatolenticular degeneration. (Wilson's disease).
    Spellberg MA
    Am J Gastroenterol; 1969 Aug; 52(2):121-6. PubMed ID: 4979739
    [No Abstract]   [Full Text] [Related]  

  • 18. Wilson's disease patients with normal ceruloplasmin levels.
    Yüce A; Koçak N; Ozen H; Gürakan F
    Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic aspects of Wilson's disease: a review.
    SIMPSON JF
    Med Bull (Ann Arbor); 1963; 29():145-54. PubMed ID: 13977562
    [No Abstract]   [Full Text] [Related]  

  • 20. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R; Kaur G; Walia BN
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.